Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Financial Position

v3.23.1
Condensed Consolidated Statements of Financial Position - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current:    
Cash and cash equivalents $ 6,362 $ 12,449
Restricted cash 327 439
Accounts receivable, net 2,648 2,252
Prepaids, deposits and other receivables 3,778 2,708
Inventories, net 8,015 8,399
Total current assets 21,130 26,247
Investment – Cansativa 5,753 5,679
Property, plant and equipment, net of accumulated depreciation of $7,531 and $7,120 for March 31, 2023 and December 31, 2022, respectively 13,491 13,963
Asset held for sale - Land 1,500 1,500
Intangible assets, net 3,164 3,354
Operating lease right-of-use assets, net 1,144 1,303
Other non-current assets 54 52
Total Assets 46,236 52,098
Current:    
Accounts payable 1,776 2,299
Accrued expenses and other current liabilities 3,826 4,238
Loans and borrowings, current portion 457 465
Warrant liability 157 113
Operating lease liabilities, current portion 599 1,239
Deferred revenue 988 1,072
Total current liabilities 7,803 9,426
Loans and borrowing — long-term 1,020 1,065
Operating lease liabilities — long-term 619 1,087
Other long-term liabilities 24 112
Total Liabilities 9,466 11,690
Contingencies and commitments
Shareholders’ equity    
Preferred shares, without par value, unlimited shares authorized, nil shares issued and outstanding for each of March 31, 2023 and December 31, 2022 0 0
Common shares, without par value, unlimited shares authorized: 44,007,272 and 43,636,783 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 0 0
Additional paid-in capital 221,756 221,313
Accumulated deficit (184,986) (180,905)
Total shareholders' equity 36,770 40,408
Total liabilities and shareholders' equity $ 46,236 $ 52,098